Fig. 2
From: Cardiopulmonary risk in the COPD patient: the EPOCONSUL audit
A) Distribution of CVD by risk level of COPD according to GesEPOC. The difference is significant (p < 0,001) between high-risk vs. low-risk level. B) Distribution of CVD according to clinical phenotypes GesEPOC. Significant difference (p < 0.001) between non-exacerbating phenotype vs. frequent exacerbating phenotypes. C) Distribution of CVD according to Type GOLD. Significant difference (p < 0.001) between GOLD types.
